Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PECS II block with ropivacaine versus placebo for postoperative analgesia in trans-axillary thoracic outlet decompression
NL-OMON49807Active, not recruiting
- Sponsor
- Catharina Ziekenhuis
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in neurogenic thoracic outlet syndrome (NTOS) comparing PECS II block with ropivacaine with PECS II block with placebo (2 arms). Primary endpoints: Postoperative pain intensity and Opioid consumption. Started Aug 2020; status: active, not recruiting.
02
Drugs
ropivacaine
03
Conditions
neurogenic thoracic outlet syndrome (NTOS)
Beyond the preview
Go deeper on NL-OMON49807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49807.